RxDoctor Payments Data

Regan Brown, PA

Physician Assistant · Spokane, WANPI 1831524875

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $36,675 of the $56,266 with a category attached, or 65.2%. Lilly USA, LLC accounts for 83.2% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $18,424, more than ten times the $1,174 reported in 2021. Among physician assistant clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,266in general payments, 2019–2025

Across 441 payments — averaging $127.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$47K
  • UCB, Inc.$2K
  • Johnson & Johnson$2K
  • AbbVie$2K
  • Regeneron Healthcare Solutions, Inc.$448
  • E.r. Squibb & Sons, L.L.C.$379
  • plus $3K from 22 others

What the payments were for

  • Consulting fees$3,7637%
  • Speaking & faculty fees$36,67565%
  • Travel & lodging$6,35811%
  • Food & beverage$9,15816%
  • Education$3131%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,266 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington

Medicare billing

Part B allowed, 2024
$138,536
Medicare patients
530
Services billed
2,710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab85$316,889
Taltz AutoinjectorIxekizumab42$312,302
Humira PenAdalimumab12$193,390
Dupixent SyringeDupilumab29$109,782
Clobetasol Propionate133$7,171
Ketoconazole92$1,565
Doxycycline Monohydrate46$1,347
Triamcinolone Acetonide101$1,265
Betamethasone Valerate24$1,234
Betamethasone Dipropionate22$1,058
Azelaic Acid11$946
Metronidazole13$928
Clindamycin Phosphate25$870
Fluocinonide18$716
Mupirocin72$651

Paid to pharmacies, not to this prescriber.

Other physician assistant in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →